Presenting Groundbreaking Advances at Onco Startup Summit 2024

PepKon is excited to participate in the upcoming Onco Startup Summit 2024, taking place during the IFODS Congress in Paris. As one of 10 selected startups, we will have the opportunity to present our innovative approach to peptide-based cancer therapies before a panel of oncologists, investors, and potential partners.
Representing PepKon, Jonathan Levy, our CEO, will highlight our latest advancements in AI-assisted peptide drug discovery, computational peptide design, and targeted peptide cancer treatments. This event provides a unique stage to engage with leading experts and discuss the future of peptide therapeutics development in oncology.
We extend our gratitude to the Onco Startup Summit organizers for creating this invaluable opportunity to share and collaborate within the biotech and oncology community.
We look forward to connecting with key players in the industry and continuing our mission to advance AI-driven peptide drug discovery and revolutionize oncology-focused peptide engineering.